Brief: Orion Pharma's ODM-212 Gets Orphan Designation From European Commission
23/06/2026 07:35
BRIEF-Orion Pharma's ODM-212 Gets Orphan Designation From European Commission June 23 (Reuters) - Orion Oyj ORNBV.HE:
ORION PHARMA'S ODM-212 GRANTED ORPHAN DESIGNATION FOR THE TREATMENT OF MALIGNANT MESOTHELIOMA BY THE EUROPEAN COMMISSION
Source text: ID:nGNE7xW9hC
Further company coverage: ORNBV.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))